Psychopharmacology and Psychiatry Updates Beyond Dopamine: Cannabidiol in Parkinson's Care
Oct 18, 2024
Join Gregory Pontone, an expert in psychopharmacology, as he discusses groundbreaking insights on using medical cannabis to treat Parkinson's disease. He reveals a study showing that 87% of patients experienced symptom improvements, challenging conventional treatments. Pontone dives into practical dosages, potential risks, and personalizing care for optimal results. Could this be the versatile answer for managing both motor and non-motor symptoms? Tune in for fascinating revelations about the future of Parkinson's care!
AI Snips
Chapters
Transcript
Episode notes
Medical Cannabis Potential in Parkinson's
- Medical cannabis shows potential for improving both motor and non-motor Parkinson's symptoms.
- However, individual patient responses and formulations vary widely, affecting results.
Symptom Improvement & Risks
- 87% of patients experienced improvement in at least one symptom after starting medical cannabis.
- Yet, 28% had worsening symptoms, highlighting mixed effects in Parkinson's treatment.
Opioid Reduction Benefit
- Over half of opioid-using Parkinson's patients reduced or stopped opioids when using medical cannabis.
- This opioid reduction could lower fall risk and related complications for patients.